News

Demetra Launches Global Spine Division Following Acquisition of OrthoFundamentals LLC

Global medical technology leader Demetra has announced the launch of its new spine-focused division, Demetra Spine, following its strategic acquisition of U.S.-based OrthoFundamentals LLC, a company renowned for sterile-packed implants and intuitive single-use surgical kits for sacroiliac (SI) joint fusion procedures.

The acquisition marks a pivotal expansion for Demetra, a company with over four decades of expertise in prosthesis fixation, orthobiologics, and infection control. With this move, Demetra aims to accelerate innovation in spinal surgery and meet the rising demand for efficient, value-based surgical solutions worldwide.

Boosting Technological and Clinical Capabilities
By acquiring OrthoFundamentals, Demetra significantly strengthens its presence in the spine surgery segment. The deal builds on Demetra’s previous strategic acquisitions, including Switzerland-based Getset Surgical and a key asset purchase from Bespoke Technologies. These past deals brought cutting-edge sterile-packed, single-use procedure kits and 3D-printed titanium implants for ACDF (anterior cervical discectomy and fusion) procedures into Demetra’s growing portfolio.

Become a valued research partner with ushttps://www.towardshealthcare.com/schedule-meeting

The integration of OrthoFundamentals’ single-use implant kits aligns with Demetra’s mission to eliminate reprocessing, reduce the risk of surgical site infections, and improve operating room efficiency especially in ambulatory surgical centers (ASCs), where demand for outpatient spine surgery is rapidly increasing.

Industry Voices Welcome the Merger
Mathew Palmer, Founder and CEO of OrthoFundamentals, expressed optimism about the partnership:

“There was a joint vision and natural synergy between Demetra and us. We identified pain points in spine surgical solutions especially in outpatient ASC settings. With Demetra’s backing, we aim to lead the market with sterile, ready-to-use, single-use systems that make a real difference.”

Ted Bird, Vice President of Demetra Spine, North America, added:

“Demetra is bringing a unique portfolio of ‘surgery-in-a-box’ kits to market fully prepped for hospitals and ASCs. Our goal is to become a leader in the fast-growing outpatient spine surgery market by offering efficient, infection-resistant, and cost-effective solutions.”

A Strategic Leap in Spinal Innovation
With over 3 million lives impacted by Demetra’s orthopedic solutions globally, the creation of Demetra Spine represents a major step in scaling the company’s legacy into the spinal health space. Leveraging its scientific, technological, and engineering strengths, Demetra is poised to offer spine surgeons transformative tools tailored for both high-acuity hospitals and fast-paced outpatient environments.

Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

Request a customized case study tailored to your business needs and gain deeper insights into healthcare market strategies: sales@towardshealthcare.com

sanskruti sathe

Recent Posts

Mabwell’s CDH17-Targeting Cancer Drug 7MW4911 Receives IND Approvals from NMPA and FDA

Chinese biopharmaceutical innovator Mabwell has announced a major milestone in its oncology pipeline: its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,… Read More

2 hours ago

New Disease Mechanism Suspected in Ovarian Cancer Remission Patients, Landmark Study Reveals

A groundbreaking multi-institutional study has uncovered a hidden mechanism potentially responsible for the high recurrence rate in ovarian cancer patients,… Read More

3 hours ago

Glioblastoma Funding Sees Surge as Nonprofits Drive Renewed Pharma Interest

In a promising turn for brain cancer research, funding for glioblastoma (GBM) has seen a significant uptick, spurred by nonprofit… Read More

3 hours ago

Lotte Biologics Accelerates Global CDMO Expansion Across North America and Asia

Seoul, South Korea  Lotte Biologics is making significant strides in expanding its global presence in the Contract Development and Manufacturing… Read More

3 hours ago

Medical Imaging Market Is on the Rising in Europe!

The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More

21 hours ago

Continuous Glucose Monitoring (CGM) Devices Market Trends in Canada

The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More

21 hours ago